Why the study?
Does tissue-specific overexpression of hCabin1 reduce disease severity in a mouse model of collagen-induced arthritis?
Does tissue-specific overexpression of hCabin1 reduce disease severity in a mouse model of collagen-induced arthritis?
Tissue-specific overexpression of hCabin1 in mouse synovial tissue suppresses the clinical and pathological severity of collagen-induced arthritis, suggesting a potential therapeutic target for chronic inflammatory conditions.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for hCabin1 modulation in experimental arthritis; human studies required before clinical consideration.
Calcineurin (CN) is a calcium- and calmodulin-dependent serine/threonine phosphatase. In immune cells, CN controls the activity of a wide range of transcription factors, including nuclear factor of activated T, nuclear factor-kappa B, c-fos, and Elk-1. CN plays an important role in synoviocyte activation and arthritis progression in vivo and this function is tightly linked to dysregulated intracellular Ca(2+) store and Ca(2+) response triggered by proinflammatory cytokines. In the present study, transgenic mice expressing human calcineurin-binding protein 1 (hCabin1) were generated, driven by type II collagen promoter, and the efficiency of these mice was investigated by experimental arthritis. These transgenic mice successfully expressed hCabin1 in joint tissue as well as other organs such as liver, heart, and brain. The overexpression of hCabin1 reduced the disease severity during collagen-induced arthritis. In fibroblast-like synoviocytes (FLSs) from hCabin1 transgenic mice, the productions of these cytokines, including interleukin (IL)-2, IL-4, and IFN-γ, were decreased and matrix metalloproteinases were also depressed in transgenic mice FLS. In addition, these effects were only found in the joint tissue, which is a major inflammation site. These findings will provide a better knowledge of the pathogenic mechanisms of rheumatoid arthritis and a potential animal model of the chronic inflammatory conditions, including atherosclerosis and transplantation.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: